DETERMINING THE PROPORTION OF ISCHEMIC STROKE PATIENTS PRESENTING TO RMI WHO ARE CANDIDATES FOR THROMBOLYSIS
Introduction: Ischemic Stroke associated mortality and morbidity severely and detrimentally effects a person’s life
and hence it is proposed as the most feared vascular event (1). Recombinant tissue plasminogen activator (rt-PA) is a
standard therapy approved for acute ischemic stroke (2). Medical history of the patient suffering a stroke is usually a
complicated clinical picture which makes the decision to utilize rt-PA even more complex (9). It is this complexity that
has created a reticence in the local medical community towards prompt acute stroke care.
Materials & Methods: The study used a quantitative cross-sectional design. Standard thrombolytic checklist was used